New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Approximately 1 in 8 people with HIV are aware they are infected. — -- Last year's announcement by actor Charlie Sheen that he had been diagnosed with HIV put renewed attention on the disease ...